The immune system responds to acute tissue damage after myocardial infarction (MI) and
orchestrates healing and recovery of the heart. However, excessive inflammation may lead …

Following a myocardial infarction (MI), the immune system helps to repair ischaemic
damage and restore tissue integrity, but excessive inflammation has been implicated in …

Following acute occlusion of a coronary artery causing myocardial ischemia and
implementing first-line treatment involving rapid reperfusion, a dynamic and balanced …

The high incidence of heart failure secondary to myocardial infarction (MI) has been difficult
to effectively address. MI causes strong aseptic inflammation, and infiltration of different …

The immune system is intimately involved in the pathophysiology of heart failure. However, it
is currently underused as a therapeutic target in the clinical setting. Moreover, the …

Highlights•Current research focus on cardioprotective immune-targeted therapeutic
approaches.•Ischemic preconditioning is a powerful cardioprotective treatment.•The immune …

Myocardial infarction (MI) is an irreversible damage of the heart muscle, which often leads to
adverse cardiac remodeling and progressive heart failure. After MI, immune cells play a vital …

Myocardial infarction is associated with an immune response. Physiological inflammation
response causes self-repair and protection, while pathological autoimmune response leads …

Purpose Despite modern reperfusion and pharmacologic therapies, myocardial infarction
(MI) remains a leading cause of morbidity and mortality worldwide. Therefore, the …

Heart failure (HF) is a leading cause of mortality and morbidity in western countries and
occasions major expenses for public health systems. Although optimal medical treatment is …